• Study on the Effects of Oral N-Acetylcysteine for Patients with Retinitis Pigmentosa

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany The Netherlands

  • Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study on REGN9933 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Hungary Latvia Lithuania Poland

  • Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Study of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Ireland Italy +5

  • Study of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark The Netherlands

  • Study on How Rabbit Anti-Human Thymocyte Immunoglobulin Helps Prevent Graft-versus-Host Disease in Children and Adults Undergoing Stem Cell Transplants

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Starting Valsartan, Sacubitril, and Empagliflozin for Patients with Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Portugal

  • Study on Reducing Proton Pump Inhibitor Use in Patients with Heartburn, Reflux, or Dyspepsia: Comparing On-Demand Use, Alginate Therapy, and Gradual Dose Reduction

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Study on the Effects of Obexelimab for Patients with IgG4-Related Disease

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Italy The Netherlands Poland +2

powered by